Princeton University awarded honorary degrees to the following recipients during the 2025 Commencement ceremony on Tuesday, ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

Vanzacaftor / tezacaftor / deutivacaftor, produced by Vertex Pharmaceuticals Incorporated under the ... Additional therapies include mucus-thinning drugs, bronchodilators, chest physical therapy, ...

And welcome to the Vertex Pharmaceuticals Third Quarter 2024 ... Finally, in CF, VX-522, our CFTR mRNA therapy, in development with our partners at Moderna, has completed the single ascending ...

During the pre-election period, 22 May to 5 July 2024, restrictions imposed on public bodies meant NICE was prevented from publicising its work. We did still continue developing useful and useable ...

This underlines the importance of Casgevy to Vertex. It's possible the therapy could generate double ... in their quality of life, including physical, emotional, social/family, and functional ...

Accurate in-vivo verification of beam range and dose distribution is crucial for the safety and effectiveness of particle therapy. Prompt gamma (PG ... including gamma electron vertex imaging (GEVI), ...

The agency is expected to complete the review of Vertex Pharmaceuticals ... months. The therapy also led to sustained and clinically meaningful improvements in aspects of patients’ health-related ...

During the randomized phase of the trial, the patients were seen every 3 months for history taking, physical examination, and laboratory testing to monitor the effects of peginterferon therapy and ...